← All articles

My options · Migraine

Treating migraine in menopause: your options

Migraine in midlife responds well to a personalized, stepwise plan, one that combines lifestyle strategies, non-drug approaches, and medication where needed. It’s worth building that plan with your healthcare provider, and a headache diary kept for at least eight weeks (recording when headaches occur, possible triggers, medications taken, and how attacks relate to hot flashes or menstrual bleeding) makes it far easier.

Acute (“as-needed”) treatments

For headaches as they occur, early treatment is most effective. Over-the-counter options such as acetaminophen or NSAIDs (like ibuprofen or naproxen) are often first-line. If those don’t work or aren’t suitable, migraine-specific medications such as triptans may be prescribed, and if nausea comes with the migraine, your clinician can prescribe an anti-nausea medication. The important caution: don’t use acute migraine medications too often, since frequent use can lead to medication-overuse headache.

Preventive (regular) treatments

For women with frequent or disabling migraines, a preventive treatment may be considered, including beta-blockers, anticonvulsants, or certain antidepressant medications.

Menopausal hormone therapy (MHT)

Having migraines, even with aura, does not automatically mean you can’t use MHT. If you have migraine with aura, your practitioner may recommend transdermal rather than oral estrogen and will assess your risks carefully. Where MHT is indicated, the general advice is the lowest effective dose, using transdermal estrogen (patch or gel) for steadier hormone levels. Oral regimens tend to cause more hormone fluctuation and may worsen migraines.

For migraine, steadiness is the goal: transdermal, lowest effective dose, because it’s the swings that trigger attacks.

If you have other cardiovascular risk factors that raise stroke risk, uncontrolled high blood pressure, high cholesterol, diabetes, or current smoking, hormone therapy may not be right for you, and other therapies may be safer.

A non-hormonal option

Venlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant, has proven effectiveness in reducing both migraine frequency and vasomotor symptoms, making it a valuable option for women who cannot or should not use estrogen therapy.

When to seek help

Seek medical care right away for any sudden or severe change in your headache pattern: a “worst ever” or sudden, explosive (“thunderclap”) headache, or a headache with new neurological symptoms such as weakness, numbness, difficulty speaking, vision loss, confusion, or seizures. Also get urgent help for a new headache after age 50, usual headaches that progressively worsen or change pattern, a headache after a head injury, or headache with fever or neck stiffness. And book an appointment soon if your migraines are becoming more frequent or severe, if you need acute medication more than 2 days per week, or if you notice new or prolonged aura that differs from your usual pattern.

A sudden “worst ever” or “thunderclap” headache, or a headache with weakness, numbness, trouble speaking, vision loss, confusion, or seizures, needs emergency assessment right away.

References

  1. Pavlović JM. Evaluation and management of migraine in midlife women. Menopause. 2018 Aug;25(8):927-929. doi:10.1097/GME.0000000000001104.
  2. MacGregor EA. Migraine, menopause and hormone replacement therapy. Post Reprod Health. 2018 Mar;24(1):11-18. doi:10.1177/2053369117731172.
  3. Sacco S, Merki-Feld GS, Egidius KL, et al; EHF and ESC. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain. 2017 Oct 30;18(1):108. doi:10.1186/s10194-017-0815-1.
  4. Bushnell C, Kernan WN, Sharrief AZ, et al. 2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2024;55(12):e344-e424. doi:10.1161/STR.0000000000000475.
  5. Ashina S, Terwindt GM, Steiner TJ, et al. Medication overuse headache. Nat Rev Dis Primers. 2023 Feb 2;9(1):5. doi:10.1038/s41572-022-00415-0.
  6. Tzankova V, Becker WJ, Chan TLH. Diagnosis and acute management of migraine. CMAJ. 2023 Jan 30;195(4):E153-E158.
  7. Ornello R, De Matteis E, Di Felice C, et al. Acute and Preventive Management of Migraine during Menstruation and Menopause. J Clin Med. 2021 May 24;10(11):2263. doi:10.3390/jcm10112263.

This article is general information, not medical advice. Any decision about managing menopause symptoms should be made with your own healthcare provider.

The Effica Clinical Team
Medically reviewed · Effica Health

Effica’s clinical guides are prepared by our health team and reflect current Canadian and international menopause guidelines. They’re general information, not a substitute for personalized medical advice.